AllSquare Wealth Management’s Edesa Biotech EDSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2 Hold
1
﹤0.01% 538
2025
Q2
$2 Hold
1
﹤0.01% 539
2025
Q1
$2 Hold
1
﹤0.01% 538
2024
Q4
$2 Hold
1
﹤0.01% 539
2024
Q3
$4 Hold
1
﹤0.01% 542
2024
Q2
$4 Hold
1
﹤0.01% 536
2024
Q1
$4 Hold
1
﹤0.01% 534
2023
Q4
$5 Hold
1
﹤0.01% 533
2023
Q3
$6 Hold
1
﹤0.01% 543
2023
Q2
$9 Hold
1
﹤0.01% 563
2023
Q1
$9 Hold
1
﹤0.01% 556
2022
Q4
$22 Hold
1
﹤0.01% 530
2022
Q3
$0 Hold
1
﹤0.01% 510
2022
Q2
$0 Hold
1
﹤0.01% 511
2022
Q1
$0 Hold
1
﹤0.01% 513
2021
Q4
$0 Hold
1
﹤0.01% 498
2021
Q3
$0 Hold
1
﹤0.01% 486
2021
Q2
$0 Hold
1
﹤0.01% 501
2021
Q1
$0 Hold
1
﹤0.01% 496
2020
Q4
$0 Hold
1
﹤0.01% 466
2020
Q3
$0 Hold
1
﹤0.01% 469
2020
Q2
$0 Hold
1
﹤0.01% 472
2020
Q1
$0 Hold
1
﹤0.01% 460
2019
Q4
$0 Hold
1
﹤0.01% 452
2019
Q3
$0 Hold
1
﹤0.01% 457
2019
Q2
$0 Sell
1
-1
-50% -$44 ﹤0.01% 461
2019
Q1
$0 Buy
+2
New +$99 ﹤0.01% 467

Other funds holding EDSA

AllSquare Wealth Management's EDSA Position: Q3 2025 in Review

AllSquare Wealth Management held its Edesa Biotech (EDSA) position steady in Q3 2025 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #538.

AllSquare Wealth Management first reported a position in EDSA in Q1 2019 and has held it in 27 quarters since. The position peaked at $22 in Q4 2022. 23 funds tracked by Wall St. Rank hold EDSA as of Q3 2025.

  • AllSquare Wealth Management held 1 share of Edesa Biotech worth $2 as of Q3 2025.
  • AllSquare Wealth Management left its Edesa Biotech share count unchanged in Q3 2025.
  • Edesa Biotech made up ﹤0.01% of AllSquare Wealth Management's portfolio in Q3 2025, its #538 holding.
  • AllSquare Wealth Management first reported a position in Edesa Biotech in Q1 2019 and has held it in 27 quarters since.
  • AllSquare Wealth Management's Edesa Biotech position peaked at $22 in Q4 2022.
  • 23 funds tracked by Wall St. Rank held Edesa Biotech as of Q3 2025.

Based on AllSquare Wealth Management's 13F filing for Q3 2025, filed 12 Jan 2026.